Harris RZ - Search Results

1

Pharmacokinetics and its role in small molecule drug discovery research.

Jang GR, Harris RZ, Lau DT. Jang GR, et al. Among authors: harris rz. Med Res Rev. 2001 Sep;21(5):382-96. doi: 10.1002/med.1015. Med Res Rev. 2001. PMID: 11579439 Review.

2

Dietary effects on drug metabolism and transport.

Harris RZ, Jang GR, Tsunoda S. Harris RZ, et al. Clin Pharmacokinet. 2003;42(13):1071-88. doi: 10.2165/00003088-200342130-00001. Clin Pharmacokinet. 2003. PMID: 14531721 Review.

3

Drug interactions involving ethanol and alcoholic beverages.

Jang GR, Harris RZ. Jang GR, et al. Among authors: harris rz. Expert Opin Drug Metab Toxicol. 2007 Oct;3(5):719-31. doi: 10.1517/17425255.3.5.719. Expert Opin Drug Metab Toxicol. 2007. PMID: 17916057 Review.

4

Pharmacokinetics and pharmacodynamics of cinacalcet in hepatic impairment : phase I, open-label, parallel-group, single-dose, single-centre study.

Padhi D, Harris RZ, Salfi M, Noveck RJ, Sullivan JT. Padhi D, et al. Among authors: harris rz. Clin Drug Investig. 2008;28(10):635-43. doi: 10.2165/00044011-200828100-00004. Clin Drug Investig. 2008. PMID: 18783302 Clinical Trial.

5

Pharmacokinetics of cinacalcet hydrochloride when administered with ketoconazole.

Harris RZ, Salfi M, Sullivan JT, Padhi D. Harris RZ, et al. Clin Pharmacokinet. 2007;46(6):495-501. doi: 10.2165/00003088-200746060-00003. Clin Pharmacokinet. 2007. PMID: 17518508 Clinical Trial.

6

The pharmacokinetics of cinacalcet are unaffected following consumption of high- and low-fat meals.

Padhi D, Salfi M, Harris RZ. Padhi D, et al. Among authors: harris rz. Am J Ther. 2007 May-Jun;14(3):235-40. doi: 10.1097/01.mjt.0000212703.71625.26. Am J Ther. 2007. PMID: 17515696 Clinical Trial.

7

Pharmacokinetics of desipramine HCl when administered with cinacalcet HCl.

Harris RZ, Salfi M, Posvar E, Hoelscher D, Padhi D. Harris RZ, et al. Eur J Clin Pharmacol. 2007 Feb;63(2):159-63. doi: 10.1007/s00228-006-0129-8. Epub 2006 May 8. Eur J Clin Pharmacol. 2007. PMID: 16680561 Clinical Trial.

8

Pharmacokinetics of a hematoregulatory peptide (SK&F107647) in healthy male volunteers and in patients with colorectal or pancreatic adenocarcinoma not amenable to standard therapy.

Zia-Amirhosseini P, Harris RZ, Cowley HC, Valle JW, Citerone DR, Boppana VK, Scarffe H, Watson P, Davis CB. Zia-Amirhosseini P, et al. Among authors: harris rz. Pharm Res. 2000 Apr;17(4):385-90. doi: 10.1023/a:1007512617139. Pharm Res. 2000. PMID: 10870980

9

Pharmacokinetics, pharmacodynamics, and safety of cinacalcet hydrochloride in hemodialysis patients at doses up to 200 mg once daily.

Harris RZ, Padhi D, Marbury TC, Noveck RJ, Salfi M, Sullivan JT. Harris RZ, et al. Am J Kidney Dis. 2004 Dec;44(6):1070-6. doi: 10.1053/j.ajkd.2004.08.029. Am J Kidney Dis. 2004. PMID: 15558528 Clinical Trial.

10

No effect of renal function or dialysis on pharmacokinetics of cinacalcet (Sensipar/Mimpara).

Padhi D, Harris RZ, Salfi M, Sullivan JT. Padhi D, et al. Among authors: harris rz. Clin Pharmacokinet. 2005;44(5):509-16. doi: 10.2165/00003088-200544050-00004. Clin Pharmacokinet. 2005. PMID: 15871636

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters